These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21328292)

  • 1. Pharmacologic treatment of depression in multiple sclerosis.
    Koch MW; Glazenborg A; Uyttenboogaart M; Mostert J; De Keyser J
    Cochrane Database Syst Rev; 2011 Feb; (2):CD007295. PubMed ID: 21328292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatment for memory disorder in multiple sclerosis.
    He D; Zhou H; Guo D; Hao Z; Wu B
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008876. PubMed ID: 21975787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic interventions for treating phantom limb pain.
    Alviar MJ; Hale T; Dungca M
    Cochrane Database Syst Rev; 2011 Dec; (12):CD006380. PubMed ID: 22161403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression.
    Baumeister H; Hutter N; Bengel J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008381. PubMed ID: 23235661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuation and maintenance treatments for depression in older people.
    Wilkinson P; Izmeth Z
    Cochrane Database Syst Rev; 2012 Nov; 11():CD006727. PubMed ID: 23152240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergics for urinary symptoms in multiple sclerosis.
    Nicholas RS; Friede T; Hollis S; Young CA
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004193. PubMed ID: 19160231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine for fatigue in multiple sclerosis.
    Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S
    Cochrane Database Syst Rev; 2010 Feb; (2):CD007280. PubMed ID: 20166093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine for fatigue in multiple sclerosis.
    Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD007280. PubMed ID: 22592719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for ataxia in multiple sclerosis.
    Mills RJ; Yap L; Young CA
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005029. PubMed ID: 17253537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate for multiple sclerosis.
    Gray O; McDonnell GV; Forbes RB
    Cochrane Database Syst Rev; 2004; 2004(2):CD003208. PubMed ID: 15106195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, acceptability, and tolerability of antidepressant treatments for patients with post-stroke depression: a network meta-analysis.
    Qin B; Chen H; Gao W; Zhao LB; Zhao MJ; Qin HX; Chen W; Chen L; Yang MX
    Braz J Med Biol Res; 2018; 51(7):e7218. PubMed ID: 29742266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocebo in clinical trials for depression: a meta-analysis.
    Mitsikostas DD; Mantonakis L; Chalarakis N
    Psychiatry Res; 2014 Jan; 215(1):82-6. PubMed ID: 24210741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis.
    Spineli LM; Higgins JP; Cipriani A; Leucht S; Salanti G
    Clin Trials; 2013; 10(3):378-88. PubMed ID: 23321265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized (N-of-1) Trials for Depression: A Systematic Review.
    Kronish IM; Hampsey M; Falzon L; Konrad B; Davidson KW
    J Clin Psychopharmacol; 2018 Jun; 38(3):218-225. PubMed ID: 29596148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain.
    Dworkin RH; Katz J; Gitlin MJ
    Neurology; 2005 Dec; 65(12 Suppl 4):S7-19. PubMed ID: 16385107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.
    Perez N; Langlest F; Mallet L; De Pieri M; Sentissi O; Thorens G; Seragnoli F; Zullino D; Kirschner M; Kaiser S; Solmi M; Sabé M
    Eur Neuropsychopharmacol; 2023 Nov; 76():61-76. PubMed ID: 37557019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invited Commentary: Assessing treatment effects by using observational analyses--opportunities and limitations.
    Wang PS; Schoenbaum M
    Am J Epidemiol; 2009 Aug; 170(3):286-7; discussion 288. PubMed ID: 19498072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.